Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Oncol Rep ; 50(1)2023 07.
Artículo en Inglés | MEDLINE | ID: mdl-37264970

RESUMEN

Lentinan (LNT) isolated from Lentinus edodes is a vital host defense potentiator previously utilized as an adjuvant in cancer therapy. The present study investigated the effect of LNT on the mouse hepatocellular carcinoma (HCC) cell line Hepa1­6 and its possible mechanism. Mouse HCC apoptosis and its potential associated mechanism were then explored using in vitro and in vivo approaches. For in vitro approaches, the effect of LNT on the proliferation of Hepa1­6 cells was investigated by Cell Counting Kit­8 assay. Annexin V­FITC staining and flow cytometry were applied to explore HCC apoptosis. Western blotting was used to analyze related proteins, such as EGR1, phosphatase and tensin homolog (PTEN), phosphorylated protein kinase B (p­Akt), protein kinase B (Akt), B lymphocyte­2 (Bcl­2), Bcl2 family­associated X protein (Bax), etc. Cellular immunofluorescence staining was employed to assess the localization and expression of EGR1 and PTEN in nuclear and cytoplasmic fractions of Hepa1­6 cells. The association between EGR1 and PTEN was explored by EGR1 overexpression in cell lines. For in vivo methods, a mouse model of diethylnitrosamine (DEN)­induced primary liver cancer was established using C57BL/6 mice to investigate the inhibitory effect of LNT on liver cancer. Histopathology of liver tissue from mice was detected by hematoxylin­eosin staining and immunohistochemical assay. In vitro and in vivo results showed that LNT can inhibit the proliferation and promote the apoptosis of mouse HCC cells. Besides, LNT increased the expression of EGR1 in Hepa1­6 cells, which is translocated to the nucleus to function as a transcriptional factor. EGR1 then activates the expression of the tumor suppressor PTEN, thereby inhibiting the activation of the AKT signaling pathway. These data revealed a novel anti­tumor mechanism by which LNT can induce apoptosis to inhibit mouse HCC progression through the EGR1/PTEN/AKT axis. These results provide a scientific basis for the potential use of LNT in drug development and clinical applications associated with primary liver cancer.


Asunto(s)
Carcinoma Hepatocelular , Neoplasias Hepáticas , Ratones , Animales , Proteínas Proto-Oncogénicas c-akt/metabolismo , Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/metabolismo , Lentinano/farmacología , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Línea Celular Tumoral , Ratones Endogámicos C57BL , Ratones Endogámicos , Transducción de Señal , Apoptosis , Fosfohidrolasa PTEN/genética , Fosfohidrolasa PTEN/metabolismo , Proliferación Celular , Proteína 1 de la Respuesta de Crecimiento Precoz/genética , Proteína 1 de la Respuesta de Crecimiento Precoz/metabolismo
2.
Acta Sci Pol Technol Aliment ; 19(3): 279-289, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32978911

RESUMEN

BACKGROUND: Recent shifts in lifestyles and diets have caused the incidence of obesity to increase rapidly, resulting in a serious threat to modern human health. There is a growing interest the use of plant or fungi derived supplements as a safe and effective means to treat obesity. In recent times, edible-medicinal fungi have garnered attention as therapeutics owing to their biocompatibility and effectiveness. Attempts to determine the therapeutic effects of these fungi have become a prime focus in drug discovery programs. Therefore, this study aimed to determine the anti-obesity effects of P. eryngii chitin in rats with obesity induced by administration of a high fat diet. METHODS: To investigate the therapeutic effects of chitin from Pleurotus eryngii on high fat diet-induce obesity, we treated obese rats with different concentrations of chitin from P. eryngii for 4 weeks, using Lipitor as positive control. The living condition, food intake, body weight, perirenal adipose tissue, periepididymal adipose tissue, adipose tissue coefficient, serum lipid levels, including total cholesterol (TC), total glyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), were measured, and levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), themalonaldehyde (MDA), and superoxide dismutase (SOD) activity in liver were determined. The rats were also monitored for pathological changes in the liver and aorta. RESULTS: These studies indicated that administration of chitin from P. eryngii could significantly decrease obese rat food utilization rates and accumulation of adipose tissue in the body, thus preventing development of increased body weight. The treatment also significantly reduced serum lipid levels, including levels of TC, TG and LDL-C. Treatment with P. eryngii-derived chitin also enhanced ALT and AST enzymatic activity, enhanced SOD enzymatic activity, and reduced the MDA content of the liver, as well as significantly reducing the liver index and alleviating liver steatosis and aortic atherosclerosis resulting from obesity. CONCLUSIONS: In conclusion, chitin from P. eryngii had therapeutic effects on hyperlipidemia, fatty liver, and aortic atherosclerosis resulting from obesity in rats.


Asunto(s)
Productos Biológicos/uso terapéutico , Peso Corporal/efectos de los fármacos , Quitina/uso terapéutico , Dieta Alta en Grasa , Metabolismo de los Lípidos/efectos de los fármacos , Obesidad/tratamiento farmacológico , Pleurotus/química , Tejido Adiposo/metabolismo , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Aterosclerosis/etiología , Aterosclerosis/prevención & control , Productos Biológicos/farmacología , Quitina/farmacología , Ingestión de Alimentos/efectos de los fármacos , Hígado Graso/etiología , Hígado Graso/prevención & control , Hiperlipidemias/etiología , Hiperlipidemias/prevención & control , Lípidos/sangre , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Masculino , Obesidad/sangre , Obesidad/complicaciones , Ratas Sprague-Dawley , Superóxido Dismutasa/sangre
3.
Appl Radiat Isot ; 126: 76-78, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28347548

RESUMEN

We have developed a quadrupole ICP-MS method for detecting sub-picogram quantities of 235U in contaminated foods. Notable features included elimination of the requirement for possessing licensed nuclear materials so that non-radiochemical laboratories may perform this analysis in the event of a large-scale nuclear or radiological emergency calling for high sample surge capacity, elimination of several extremely hazardous reagents in sample analysis e.g. aqua regia and hydrofluoric acid, and the method was developed for applying a moderately priced, and widely used quadrupole inductively coupled plasma mass spectrometer (Q-ICP-MS). This method could be quickly implemented at many laboratories to increase emergency response capability.


Asunto(s)
Contaminación Radiactiva de Alimentos/análisis , Espectrometría de Masas/métodos , Radiometría/métodos , Uranio/análisis , Estudios de Factibilidad , Humanos , Espectrometría de Masas/normas , Radiometría/normas , Estándares de Referencia , Uranio/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA